Needham Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsApr 9 19:33 ET · Ratings

BofA Securities Initiates Neumora Therapeutics(NMRA.US) With Sell Rating, Announces Target Price $1

Moomoo NewsApr 2 19:32 ET · Ratings

Express News | Neumora Therapeutics Inc : BofA Global Research Cuts to Underperform From Buy; Cuts Price Objective to $1 From $7

ReutersApr 2 07:07 ET

Guggenheim Downgrades Neumora Therapeutics to Neutral

BenzingaMar 10 11:01 ET

William Blair Downgrades Neumora Therapeutics(NMRA.US) to Hold Rating

Moomoo NewsMar 7 16:31 ET · Ratings

Neumora Therapeutics Cut to Hold From Buy by Stifel

Dow JonesMar 7 11:48 ET · Ratings

Johnson & Johnson Stops Late-Stage Depression Study Over 'Insufficient Efficacy'

BenzingaMar 7 09:03 ET

Express News | Neumora Therapeutics Shares Down 11.2% Premarket After Johnson & Johnson Stops Studies of Rival Depression Drug

ReutersMar 7 08:58 ET

Douglas Tsao Recommends 'Buy' for Neumora Therapeutics Due to Navacaprant's Market Potential and Differentiated Pharmacology

TipRanksMar 7 08:35 ET

Neumora Therapeutics Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Dow JonesMar 7 07:54 ET · Ratings

Stifel Maintains Neumora Therapeutics(NMRA.US) With Hold Rating, Maintains Target Price $2

Moomoo NewsMar 7 07:31 ET · Ratings

Stifel Downgrades Neumora Therapeutics(NMRA.US) to Hold Rating, Cuts Target Price to $2

Moomoo NewsMar 7 05:32 ET · Ratings

Cautious Hold Rating on Neumora Therapeutics Amid Efficacy Concerns and Clinical Trial Setbacks

TipRanksMar 7 04:56 ET · Ratings

Mizuho Securities Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Maintains Target Price $4

Moomoo NewsMar 5 07:33 ET · Ratings

Mizuho Securities Reaffirms Their Buy Rating on Neumora Therapeutics, Inc. (NMRA)

TipRanksMar 5 06:49 ET · Ratings

RBC Capital Reiterates Sector Perform on Neumora Therapeutics, Maintains $4 Price Target

BenzingaMar 4 10:04 ET · Ratings

Needham Maintains Neumora Therapeutics(NMRA.US) With Buy Rating, Cuts Target Price to $5

Moomoo NewsMar 4 08:33 ET · Ratings

Neumora Therapeutics to Present at Leerink Global Healthcare Conference

GlobeNewswireMar 4 08:30 ET

RBC Capital Downgrades Neumora Therapeutics(NMRA.US) to Hold Rating, Cuts Target Price to $4

Moomoo NewsMar 4 07:31 ET · Ratings

Express News | Needham Reiterates Buy on Neumora Therapeutics, Maintains $5 Price Target

BenzingaMar 4 07:24 ET